Tonix is enrolling in a Phase 3 study for Fibromyalgia, and Phase 2 studies for Long COVID, Chronic Migraine, and Major Depressive Disorder. Please visit Clinical Trials.
Op-eds
TNX-601 CR*: a Once-Daily Formulation of Tianeptine in Development for the Treatment of Major Depressive Disorder
Effect of Time Since Trauma on Response to TNX-102 SL* (Cyclobenzaprine Sublingual Tablets) in Military-Related PTSD Results of Two Double-Blind Randomized Placebo-Controlled Studies
Cookie Notification
We use 1st and 3rd party cookies to enhance your experience of our website, save your preferences, and provide us with information on how you use our website. For more information, please refer to our Privacy Policy. By accessing or using our website, you consent to our use of cookies. You may opt out of the use of cookies by adjusting your browser settings.